Company QHSLab, Inc.

Stocks

USAQ

US90350R1077

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 12:28:02 2026-09-15 EDT			5-day change	1st Jan Change
0.4000 ^USD	+25.00%		+25.00%	-33.98%

08-12	QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Business description: QHSLab, Inc.

QHSLab, Inc. is a medical device technology and software as a service (SaaS) company focused on primary care physicians (PCPs) and other healthcare providers to offer tools to evaluate and treat chronic diseases as well as provide preventive care through reimbursable procedures. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. It also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians.

Number of employees: 12

Sales by Activity: QHSLab, Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Diagnostic Kits / Equipment	1.41M	1.24M	1.41M	2.13M	2.69M

See all business segments

Geographical breakdown of sales: QHSLab, Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
United States	1.41M	1.24M	1.41M	2.13M	2.69M

See all geographic segments

Executive Committee: QHSLab, Inc.

Manager	Title	Age	Since
Troy Grogan CEO	Chief Executive Officer	49	2016-06-27
Jeremy Jacob CTO	Chief Tech/Sci/R&D Officer	-	-
Marcos Sanchez-Gonzalez CTO	Chief Tech/Sci/R&D Officer	-	2024-05-01
Olivia Giamanco IRC	Investor Relations Contact	-	-
Elizabeth Magdaleno PRN	Corporate Officer/Principal	-	-

See QHSLAB, INC. governance

Composition of the Board of Directors: QHSLab, Inc.

Director	Title	Age	Since
Troy Grogan CHM	Chairman	49	2016-06-27

Composition of the Board of Directors

Shareholders: QHSLab, Inc.

Name	Stocks	%	Valuation
Troy Grogan 25.57 %	3,843,164	25.57 %	1 M $
Mercer Street Global Opportunity Fund LLC 7.737 %	1,163,077	7.737 %	409 403 $
Nick Peters 7.723 %	1,161,049	7.723 %	408 689 $
Justin Smollar 7.405 %	1,113,140	7.405 %	391 825 $

Name	Stocks	%	Valuation
Troy Grogan 100 %	2,644,424	100 %	930 837 $

Name	Stocks	%	Valuation
Troy Grogan 100 %	1,080,092	100 %	380 192 $

List of QHSLAB, INC. shareholders

Company details: QHSLab, Inc.

QHSLab, Inc.

901 Northpoint Parkway

33407, West Palm Beach

+929 379 6503

http://www.usaqcorp.com

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
QHSLAB, INC.	+25.00%	+25.00%	+158.40%	+471.43%	6.01M
THERMO FISHER SCIENTIFIC, INC.	+4.61%	+6.36%	+35.18%	+24.41%	237B
DANAHER CORPORATION	+3.01%	+2.01%	+11.04%	-17.98%	147B
INTUITIVE SURGICAL, INC.	-0.21%	+7.71%	-13.09%	+27.62%	133B
BOSTON SCIENTIFIC CORPORATION	-2.62%	-2.47%	-56.07%	-17.07%	63.58B
SIEMENS HEALTHINEERS AG	-0.31%	-0.33%	-18.70%	-15.74%	49.95B
EDWARDS LIFESCIENCES CORPORATION	+0.26%	-1.13%	+12.74%	+17.13%	49.42B
AGILENT TECHNOLOGIES, INC.	+2.36%	+2.33%	+19.61%	+29.64%	42.37B
WATERS CORPORATION	+1.73%	+3.52%	+39.48%	+51.23%	40.98B
RESMED, INC.	+2.89%	+3.80%	-15.40%	+57.81%	32.82B
Average	+3.50%	+3.10%	+17.32%	+62.85%	79.67B
Weighted average by Cap.	+1.73%	+2.43%	+7.91%	+13.88%